ATE414100T1 - Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen - Google Patents

Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen

Info

Publication number
ATE414100T1
ATE414100T1 AT02760458T AT02760458T ATE414100T1 AT E414100 T1 ATE414100 T1 AT E414100T1 AT 02760458 T AT02760458 T AT 02760458T AT 02760458 T AT02760458 T AT 02760458T AT E414100 T1 ATE414100 T1 AT E414100T1
Authority
AT
Austria
Prior art keywords
peyer
spot
cells
ligand against
targeted ligand
Prior art date
Application number
AT02760458T
Other languages
English (en)
Inventor
Daniel O'mahony
Imelda Lanbkin
Lisa Higgins
Original Assignee
Merrion Res Iii Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrion Res Iii Ltd filed Critical Merrion Res Iii Ltd
Application granted granted Critical
Publication of ATE414100T1 publication Critical patent/ATE414100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT02760458T 2001-07-02 2002-06-28 Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen ATE414100T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30259101P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
ATE414100T1 true ATE414100T1 (de) 2008-11-15

Family

ID=23168408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760458T ATE414100T1 (de) 2001-07-02 2002-06-28 Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen

Country Status (8)

Country Link
US (3) US6916789B2 (de)
EP (1) EP1432729B1 (de)
JP (1) JP4383855B2 (de)
AT (1) ATE414100T1 (de)
AU (1) AU2002326070A1 (de)
CA (1) CA2451741C (de)
DE (1) DE60229867D1 (de)
WO (1) WO2003004517A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521737B1 (en) * 1995-11-10 2003-02-18 Elan Corporation, Plc Peptides which enhance transport across tissues and methods of identifying and using the same
CA2451741C (en) * 2001-07-02 2014-02-18 Elan Corporation, Plc Peyers's patch and/or m-celle targeting ligands
CA2527721C (en) * 2003-06-10 2016-05-10 University Of Saskatchewan Chimeric adenovirus capsid proteins
AU2012201102B2 (en) * 2004-06-23 2014-05-08 Ferguson, Ian Andrew Agents and methods for early diagnosis and monitoring of Alzheimer's disease and other neurological disorders
DE102005031755B9 (de) * 2005-07-01 2010-04-08 Technische Universität Dresden Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Salmonella spp.
WO2007137174A2 (en) * 2006-05-18 2007-11-29 The Ohio State University Research Foundation Compositions and methods for the detection of vulnerable plaque
PT2897620T (pt) 2012-09-21 2020-09-03 Intensity Therapeutics Inc Método de tratamento de cancro
US9815871B2 (en) 2013-04-23 2017-11-14 President And Fellows Of Harvard College Genetic reprogramming of bacterial biofilms
US20180258435A1 (en) 2015-04-06 2018-09-13 President And Fellows Of Harvard College Biosynthetic amyloid-based materials displaying functional protein sequences
US11098133B2 (en) 2016-05-19 2021-08-24 President And Fellows Of Harvard College Methods of making gels and films using curli nanofibers
US10400013B2 (en) 2016-10-26 2019-09-03 Chao-Wei Liao Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004608A1 (en) * 1985-02-05 1986-08-14 Synergen Biologicals, Inc. Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US5254342A (en) 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
WO1993020834A1 (en) 1992-04-10 1993-10-28 Brigham And Women's Hospital Methods and compositions for oral delivery of therapeutic agents
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
EP0750630A4 (de) * 1994-03-11 1998-01-07 Ariad Pharma Inc Methode und materialien zur identifizierung von inhibitoren der molekularen interaktionen, welche durch die sh3 domänen vermittelt werden
US5831008A (en) * 1994-08-18 1998-11-03 La Jolla Cancer Research Foundation Retinoblastoma protein-interacting zinc finger proteins
US6030613A (en) 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6086875A (en) 1995-01-17 2000-07-11 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of immunogens
EP1281718A3 (de) * 1995-11-10 2005-01-19 ELAN CORPORATION, Plc Peptiden die den Transport über Geweben erhöhen
IE80466B1 (en) 1995-11-10 1998-07-29 Elan Corp Plc Peptides which enhance transport across tissues and methods of identifying and using the same
US6261787B1 (en) 1996-06-03 2001-07-17 Case Western Reserve University Bifunctional molecules for delivery of therapeutics
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AU755154B2 (en) * 1997-05-15 2002-12-05 Cytogen Corporation Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
EP1230267B1 (de) * 1999-09-27 2006-03-29 Elan Corporation Membrantranslokierendes peptid als wirkstofftransportsystem
JP2001245675A (ja) * 1999-12-28 2001-09-11 Kyogo Ito 腫瘍抗原
WO2002072015A2 (en) * 2001-03-12 2002-09-19 Montana State University-Bozeman M cell directed vaccines
CN1323825A (zh) * 2000-05-16 2001-11-28 上海博德基因开发有限公司 一种新的多肽——人网格蛋白轻链9和编码这种多肽的多核苷酸
CA2443644A1 (en) * 2001-04-04 2003-01-16 Elan Corporation, Plc Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors
CA2451741C (en) * 2001-07-02 2014-02-18 Elan Corporation, Plc Peyers's patch and/or m-celle targeting ligands

Also Published As

Publication number Publication date
US7485321B2 (en) 2009-02-03
WO2003004517A2 (en) 2003-01-16
DE60229867D1 (de) 2008-12-24
US20100016549A1 (en) 2010-01-21
JP4383855B2 (ja) 2009-12-16
AU2002326070A1 (en) 2003-01-21
CA2451741A1 (en) 2003-01-16
EP1432729A2 (de) 2004-06-30
JP2005503782A (ja) 2005-02-10
US20050227924A1 (en) 2005-10-13
EP1432729B1 (de) 2008-11-12
US6916789B2 (en) 2005-07-12
WO2003004517A3 (en) 2004-04-29
US20030096354A1 (en) 2003-05-22
CA2451741C (en) 2014-02-18

Similar Documents

Publication Publication Date Title
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
ATE385806T1 (de) Fusionsproteine
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
BRPI0413449A (pt) compostos de quinoxalina
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
ATE414100T1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
EA200200545A1 (ru) Онколитические комбинации для лечения рака
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
DK1220852T3 (da) Substituerede diazepaner
SE0003476D0 (sv) Compounds
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE60310742D1 (de) Extrakt mit antitumoraler und antitoxischer wirkung
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
SE9802209D0 (sv) Novel compounds
SE0100684D0 (sv) New subject-matter
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties